Skip to content

Metabolic handling of dietary protein in critically ill patients

Effect of initiating enteral protein feeding on whole-body protein turnover in critically ill patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000333617
Enrollment
12
Registered
2014-03-27
Start date
2010-12-10
Completion date
2012-01-12
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Critically ill patients suffer from catabolism, i.e. protein loss, which may contribute to complications such as muscle weakness, protracted ventilator treatment, and delayed recovery. Appropriate feeding may alleviate catabolism, but ideal feeding strategies are controversial, partly because the underlying physiology is poorly understood. We investigate the effect of protein feeding via nasogastric feeding tube in critically ill patients. Using stable isotope techniques, we measure whether whole-body protein catabolism is improved after initiation of feeding.

Interventions

Enteral feeding is initiated in critically ill patients. Due to tolerance problems that are common in these patients, a low dose of enteral nutrition is given initially. At an infusion rate of 20 ml/h, nutrient supply is 0.73 g/h casein and 2.73 g/h maltodextrin. Study nutrition contains casein intrinsically labeled with L-[1-13C]-phenylalanine (van Loon, L.J., et al., J Dairy Sci, 2009. 92:4812-22). This allows measurement of the dietary contribution to whole-body protein kinetics. Measurements

Enteral feeding is initiated in critically ill patients. Due to tolerance problems that are common in these patients, a low dose of enteral nutrition is given initially. At an infusion rate of 20 ml/h, nutrient supply is 0.73 g/h casein and 2.73 g/h maltodextrin. Study nutrition contains casein intrinsically labeled with L-[1-13C]-phenylalanine (van Loon, L.J., et al., J Dairy Sci, 2009. 92:4812-22). This allows measurement of the dietary contribution to whole-body protein kinetics. Measurements of whole-body protein kinetics are made before and after six hours of enteral feeding.

Sponsors

Prof Olav Rooyackers
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

ICU patients who are tracheally intubated or tracheostomized; clinical indication for inititating enteral feeding

Exclusion criteria

Prior enteral feeding; milk protein allergy; ongoing renal replacement therapy or other extracorporeal blood treatment; liver failure; ongoing hemorrhage requiring transfusion; major surgery during the study period; contraindications to enteral feeding via nasogastric tube

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026